Objective To determine whether a standardised and manualised care intervention in men in primary care could achieve superior improvement of lower urinary tract symptoms (LUTS) compared with usual care.
Design Cluster randomised controlled trial.
Setting 30 National Health Service general practice sites in England.
Participants Sites were randomised 1:1 to the intervention and control arms. 1077 men (≥18 years) with bothersome LUTS recruited between June 2018 and August 2019: 524 were assigned to the intervention arm (n=17 sites) and 553 were assigned to the usual care arm (n=13 sites).
Intervention Standardised information booklet developed with patient and expert input, providing guidance on conservative and lifestyle interventions for LUTS in men. After assessment of urinary symptoms (manualised element), general practice nurses and healthcare assistants or research nurses directed participants to relevant sections of the manual and provided contact over 12 weeks to assist with
A new study posted on the pre-print medRxiv aimed to discuss how Virus Watch provided public health approaches that were effective for the investigation of community incidence, symptom profiles, and the transmission of COVID-19, as well as the effectiveness of the COVID-19 vaccines.
UKHSA Advisory Board: preparedness for infectious disease threats gov.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gov.uk Daily Mail and Mail on Sunday newspapers.
The 33 non-medical jobs available at Leicester s hospitals now leicestermercury.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leicestermercury.co.uk Daily Mail and Mail on Sunday newspapers.
In this large, randomised clinical trial in patients aged 60 years or older with ischaemic
heart disease but no history of gout, there was no difference in the primary outcome
of non-fatal myocardial infarction, non-fatal stroke, or cardiovascular death between
participants randomised to allopurinol therapy and those randomised to usual care.